{
    "Trade/Device Name(s)": [
        "Captia\u2122 Measles IgM"
    ],
    "Submitter Information": "Trinity Biotech",
    "510(k) Number": "K140455",
    "Predicate Device Reference 510(k) Number(s)": [
        "K904083"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "PCL"
    ],
    "Summary Letter Date": "May 22, 2014",
    "Summary Letter Received Date": "February 24, 2014",
    "Submission Date": "February 21, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.3520"
    ],
    "Regulation Name(s)": [
        "Rubeola (measles) virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology",
        "serology",
        "immunology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Measles IgM antibody"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ELISA microwell plate reader",
        "Spectrophotometer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-Linked Immunosorbent Assay (ELISA)"
    ],
    "Methodologies": [
        "Qualitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Calibrator",
        "Control",
        "Reagent",
        "Plate"
    ],
    "Document Summary": "FDA 510(k) summary for Trinity Biotech Captia\u2122 Measles IgM ELISA assay for qualitative detection of measles IgM antibodies in human serum.",
    "Indications for Use Summary": "Qualitative detection of measles IgM antibodies in human serum of patients suspected of measles (rubeola) infection, intended as an aid in the diagnosis of current or recent measles infection in conjunction with other clinical information and laboratory findings.",
    "fda_folder": "Microbiology"
}